<- Go Home

Medpace Holdings, Inc.

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Market Cap

$16.9B

Volume

366.9K

Cash and Equivalents

$502.7M

EBITDA

$611.2M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$2.0B

Profit Margin

72.35%

52 Week High

$677.90

52 Week Low

$373.00

Dividend

N/A

Price / Book Value

38.97

Price / Earnings

35.52

Price / Tangible Book Value

-64.62

Enterprise Value

$16.6B

Enterprise Value / EBITDA

25.24

Operating Income

$583.4M

Return on Equity

162.15%

Return on Assets

20.10

Cash and Short Term Investments

$502.7M

Debt

$144.1M

Equity

$433.9M

Revenue

$2.8B

Unlevered FCF

$510.4M

Sector

Life Sciences Tools and Services

Category

N/A

Company Stock Pitches